Valuation : Optiscan Imaging Limited

Market Cap 167M 120M 103M 97.37M 88.72M 166M 11.32B 1.15B 447M 5.79B 450M 440M 19.01B P/E 2025
-14.5x
P/E 2026 -17.1x
Enterprise Value 154M 110M 95.32M 89.79M 81.81M 153M 10.44B 1.06B 413M 5.34B 415M 406M 17.53B EV / Sales 2025
23.8x
EV / Sales 2026 31.1x
Free-Float
36.32%
Yield 2025 *
-
Yield 2026 -
1 day-9.38%
1 week-6.45%
Current month-6.45%
3 months+11.54%
6 months+70.59%
Current year+45.00%
1 week 0.14
Extreme 0.135
0.16
1 month 0.14
Extreme 0.135
0.2
Current year 0.08
Extreme 0.08
0.2
1 year 0.08
Extreme 0.08
0.2
3 years 0.07
Extreme 0.071
0.26
5 years 0.07
Extreme 0.071
0.28
10 years 0.01
Extreme 0.013
0.47
Manager TitleAgeSince
Chief Executive Officer - 2021-12-12
Director of Finance/CFO - 2025-03-30
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman - 2021-04-18
Director/Board Member - 2022-06-13
Director/Board Member - 2021-07-28
Date Insider Type Main position Quantity % Market Cap. Importance
5/22/26 Sell

Director

-3,000,000 0.2873%
1/15/26 Free

Director

230,502 0.0221%
1/15/26 Free

Chairman

419,094 0.0401%
Change 5-day change 1-year change 3-year change Capi.($)
-9.38%-6.45%+61.11%+88.31% 120M
-1.39%-1.48%-30.77%-3.87% 12.68B
-1.98%-4.26%+14.48%+4.99% 4.32B
-1.96%+0.36%-40.52%-56.77% 1.23B
-1.96%-0.54%-37.09%-40.49% 1.15B
-0.24%-1.49%+20.31%+79.71% 1.1B
+0.35%+2.28% - - 1.08B
-1.90%-0.06%-35.11% - 1.05B
-2.37%-1.16%+25.31%+104.25% 519M
+1.02%+1.89%+62.47% - 297M
Average -1.98%-1.10%+4.46%+25.16% 2.35B
Weighted average by Cap. -1.48%-1.68%-17.62%+0.39%

Financials

2025 2026
Net sales 3.72M 2.67M 2.3M 2.17M 1.98M 3.7M 252M 25.7M 9.97M 129M 10.03M 9.81M 424M 3.61M 2.59M 2.24M 2.11M 1.92M 3.59M 245M 24.93M 9.68M 125M 9.73M 9.52M 411M
Net income -6.31M -4.53M -3.91M -3.68M -3.35M -6.26M -428M -43.55M -16.9M -219M -17M -16.63M -718M -6.99M -5.01M -4.32M -4.07M -3.71M -6.93M -473M -48.2M -18.71M -242M -18.81M -18.4M -795M
Net Debt -3.07M -2.2M -1.9M -1.79M -1.63M -3.05M -208M -21.19M -8.22M -106M -8.27M -8.09M -349M -13.01M -9.33M -8.05M -7.58M -6.91M -12.91M -881M -89.75M -34.83M -451M -35.03M -34.26M -1.48B
Logo Optiscan Imaging Limited
Optiscan Imaging Limited is a commercial stage medical technology company. It creates a suite of digital pathology and precision surgery hardware and software solutions that enable live optical biopsy for life sciences, diagnostic and surgical applications. It is engaged in development, manufacturing, and commercialization of confocal endomicroscopic imaging technologies for medical, translational and pre-clinical applications. Its technology enables real-time, non-destructive, 3D, in-vivo digital imaging at the single-cell level. Its products include InVue, InForm, InVivage, ViewnVivo and InSpecta. ViewnVivo offers single-cell level live imaging, providing biological system insights and enabling users to see life connected. Developed with its patented confocal imaging technology, ViewnVivo is a miniaturized in vivo imaging device that offers single-cell 3D live microscopic imaging in the palm of your hand. InVivage is an intra-oral digital endomicroscope.
Employees
9
Date Price Change Volume
26-09-03 A$0.1450 -9.38% 49,008
26-09-02 A$0.1600 +6.67% 475,659
26-09-01 A$0.1500 -3.23% 56,275
26-08-31 A$0.1550 0.00% 353,846
26-08-28 A$0.1550 0.00% 153,510